Mast Cell-Mediated Mechanisms of Nociception
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Mast cells are tissue-resident immune cells that release immuno-modulators, chemo-attractants, vasoactive compounds, neuropeptides and growth factors in response to allergens and pathogens constituting a first line of host defense. The neuroimmune interface of immune cells modulating synaptic responses has been of increasing interest, and mast cells have been proposed as key players in orchestrating inflammation-associated pain pathobiology due to their proximity to both vasculature and nerve fibers. Molecular underpinnings of mast cell-mediated pain can be disease-specific. Understanding such mechanisms is critical for developing disease-specific targeted therapeutics to improve analgesic outcomes. We review molecular mechanisms that may contribute to nociception in a disease-specific manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Sickle Cell Anemia, a Molecular Disease
Pauling, L., Itano, H. A., Singer, S. J., & Wells, I. C. (1949) · Science · doi:10.1126/science.110.2865.543 · Cited by 2,319 · cited 1×
“Sickle cell disease (SCD) was the first molecular disease to be identified due to a single nucleotide polymorphism of hemoglobin [232].”
BackgroundPrevalence of pain in patients with cancer: a systematic review of the past 40 years
van den Beuken-van Everdingen, M. H. J., de Rijke, J. M., Kessels, A. G., Schouten, H. C., van Kleef, M., & Patijn, J. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm056 · Cited by 1,923
Barbara, G., Stanghellini, V., De Giorgio, R., Cremon, C., Cottrell, G. S., Santini, D., Pasquinelli, G., Morselli-Labate, A. M., Grady, E. F., Bunnett, N. W., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.055 · Cited by 1,475 · cited 3×
“Proximity of MCs to nerve fibers may be of substantial importance for direct interaction between the two leading to increased sensation [32].”
BackgroundAutonomic nerve development contributes to prostate cancer progression
Magnon, C., Hall, S. J., Lin, J., Xue, X., Gerber, L., Freedland, S. J., & Frenette, P. S. (2013) · Science · doi:10.1126/science.1236361 · Cited by 1,287 · cited 1×
“Cancer progression and pain may be correlated via tumor innervation [223], substance P [224] or immunomodulatory endogenous mu opioid receptors [225].”
BackgroundTryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
Schwartz, L. B., Metcalfe, D. D., Miller, J. S., Earl, H., & Sullivan, T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162603 · Cited by 784 · cited 1×
“In 1987, tryptase was identified as a highly sensitive and specific marker for MC activation [12].”
BackgroundMast Cell-Dependent Excitation of Visceral-Nociceptive Sensory Neurons in Irritable Bowel Syndrome
Barbara, G., Wang, B., Stanghellini, V., de Giorgio, R., Cremon, C., Di Nardo, G., Trevisani, M., Campi, B., Geppetti, P., Tonini, M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.039 · Cited by 783
Valent, P., Akin, C., Arock, M., Brockow, K., Butterfield, J. H., Carter, M. C., Castells, M., Escribano, L., Hartmann, K., Lieberman, P., et al. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000328760 · Cited by 654
Role for protease activity in visceral pain in irritable bowel syndrome
Cenac, N., Andrews, C. N., Holzhausen, M., Chapman, K., Cottrell, G., Andrade-Gordon, P., Steinhoff, M., Barbara, G., Beck, P., Bunnett, N. W., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29255 · Cited by 591 · cited 2×
“PAR2 may sensitize neurons via Ca2+ mobilization [143,152] and TRPV1 channel activation [154].”
BackgroundPiche, T., Barbara, G., Aubert, P., Bruley des Varannes, S., Dainese, R., Nano, J. L., Cremon, C., Stanghellini, V, De Giorgio, R., Galmiche, J. P., et al. (2009) · Gut · doi:10.1136/gut.2007.140806 · Cited by 540
Akbar, A., Yiangou, Y., Facer, P., Walters, J. R. F., Anand, P., & Ghosh, S. (2008) · Gut · doi:10.1136/gut.2007.138982 · Cited by 526
Increased mast cells in the irritable bowel syndrome
O’Sullivan, Clayton, Breslin, Harman, Bountra, Mclaren, & O’Morain (2000) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.2000.00221.x · Cited by 480
Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum
Guilarte, M., Santos, J., de Torres, I., Alonso, C., Vicario, M., Ramos, L., Martinez, C., Casellas, F., Saperas, E., & Malagelada, J. R. (2007) · Gut · doi:10.1136/gut.2006.100594 · Cited by 385 · cited 1×
“Increased tryptase levels were also found in colonic biopsies [137–139] and in the blood serum and intestinal fluid of IBS patients [134].”
BackgroundIntestinal membrane permeability and hypersensitivity in the irritable bowel syndrome
Zhou, Q., Zhang, B., & Verne, N. G. (2009) · Pain · doi:10.1016/j.pain.2009.06.017 · Cited by 373 · cited 1×
“Also, increased intestinal permeability is correlated with increased nociception in IBS patients [141,149–151].”
BackgroundSchwartz, L. B., Sakai, K., Bradford, T. R., Ren, S., Zweiman, B., Worobec, A. S., & Metcalfe, D. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118337 · Cited by 371
Buhner, S., Li, Q., Vignali, S., Barbara, G., De Giorgio, R., Stanghellini, V., Cremon, C., Zeller, F., Langer, R., Daniel, H., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.005 · Cited by 351
Terminal ileal mucosal mast cells in irritable bowel syndrome
Weston, A. P., Biddle, W. L., Bhatia, P. S., & Miner, P. B. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303164 · Cited by 338 · cited 2×
“HS [32,43,134–138,140–142, 145,147,148,152–154,160,251] RM [144,152,153,157–159]”
ResultGecse, K., Róka, R., Ferrier, L., Leveque, M., Eutamene, H., Cartier, C., Ait-Belgnaoui, A., Rosztóczy, A., Izbéki, F., Fioramonti, J., et al. (2008) · Gut · doi:10.1136/gut.2007.140210 · Cited by 314
Estradiol activates mast cells via a non-genomic estrogen receptor-α and calcium influx
Zaitsu, M., Narita, S.-I., Lambert, K. C., Grady, J. J., Estes, D. M., Curran, E. M., Brooks, E. G., Watson, C. S., Goldblum, R. M., & Midoro-Horiuti, T. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.030 · Cited by 262 · cited 1×
“MCs can be activated by estrogen via the estrogen receptor and can release MC mediators including prostaglandins [133].”
BackgroundFord, A. C., Brandt, L. J., Young, C., Chey, W. D., Foxx-Orenstein, A. E., & Moayyedi, P. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.223 · Cited by 261 · cited 1×
“MC-derived serotonin may contribute to pain in IBS as well [155,156].”
BackgroundPain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis
Anaf, V., Chapron, C., El Nakadi, I., De Moor, V., Simonart, T., & Noël, J.-C. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.057 · Cited by 258
Cremon, C., Carini, G., Wang, B., Vasina, V., Cogliandro, R. F., De Giorgio, R., Stanghellini, V., Grundy, D., Tonini, M., De Ponti, F., et al. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.86 · Cited by 223
PARK, J. H., RHEE, P., KIM, H. S., LEE, J. H., KIM, Y., KIM, J. J., & RHEE, J. C. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04143.x · Cited by 196 · cited 2×
“Increased tryptase levels were also found in colonic biopsies [137–139] and in the blood serum and intestinal fluid of IBS patients [134].”
BackgroundResultMenstruation pulls the trigger for inflammation and pain in endometriosis
Laux-Biehlmann, A., d’Hooghe, T., & Zollner, T. M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.03.004 · Cited by 150
Molderings, G. J., Brettner, S., Homann, J., & Afrin, L. B. (2011) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-4-10 · Cited by 149
The mastocytosis society survey on mast cell disorders: patient experiences and perceptions
Jennings, S., Russell, N., Jennings, B., Slee, V., Sterling, L., Castells, M., Valent, P., & Akin, C. (2014) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2013.09.004 · Cited by 143 · cited 1×
“In the largest symptom assessment in MC disease performed to date (420 patients, with 24% bearing cutaneous mastocytosis, 51% bearing systemic mastocytosis, and 12% bearing MCAS), pain was reported in the stomach, lower abdomen, joints, bones, muscle or nerve or connective tissue, upper abdomen, and chest by 73%, 56%,…”
BackgroundXavier, P., Belo, L., Beires, J., Rebelo, I., Martinez-de-Oliveira, J., Lunet, N., & Barros, H. (2006) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-005-0080-4 · Cited by 130 · cited 2×
“Increased levels of MC mediators such as IL-8, MCP-1, RANTES, and TNFα, and MC growth factor SCF have been found in the peritoneal fluid of human patients [117–122].”
BackgroundMast cells, versatile gatekeepers of pain
Chatterjea, D., & Martinov, T. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2014.03.001 · Cited by 110 · cited 2×
“29075 suggested allergic MC activation contributes to peripheral nociceptive sensitization in vulvodynia patients in absence of pruriception [19,167].”
BackgroundPossible pathophysiology of ketamine‐related cystitis and associated treatment strategies
Jhang, J., Hsu, Y., & Kuo, H. (2015) · International Journal of Urology · doi:10.1111/iju.12841 · Cited by 106
Pardanani, A. (2013) · Blood · doi:10.1182/blood-2013-01-453183 · Cited by 101 · cited 1×
“, antihistamines, leukotriene inhibitors, cromolyn, selective serotonin receptor antagonists) [44].”
BackgroundMast Cells in Allergic and Inflammatory Diseases
Sismanopoulos, N., Delivanis, D.-A., Alysandratos, K.-D., Angelidou, A., Therianou, A., Kalogeromitros, D., & C. Theoharides, T. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800165997 · Cited by 87 · cited 1×
“(For a complete list of the mediators and triggers of MCs, see review [26]).”
BackgroundHyperinnervation in Intestinal Deep Infiltrating Endometriosis
Wang, G., Tokushige, N., Russell, P., Dubinovsky, S., Markham, R., & Fraser, I. S. (2009) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2009.07.012 · Cited by 85 · cited 1×
“Endometriotic lesions showed higher expression of SP, CGRP and NK1 receptors [126–128].”
BackgroundMolderings, G. J., Kolck, U. W., Scheurlen, C., Brüss, M., Homann, J., & Von Kügelgen, I. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520701245744 · Cited by 73 · cited 1×
“The mutations in MC regulatory elements engendering aberrant MC mediator production and release [42,43] almost certainly originate in stem cells or pluripotent progenitor cells, implying the same mutations likely are present in other lineages, though the degree to which such mutations contribute to dysfunction in othe…”
BackgroundBorer‐Reinhold, M., Haeberli, G., Bitzenhofer, M., Jandus, P., Hausmann, O., Fricker, M., Helbling, A., & Müller, U. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03848.x · Cited by 73
Mast cells in chronic inflammation, pelvic pain and depression in women
Graziottin, A., Skaper, S. D., & Fusco, M. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.911280 · Cited by 63
Enestrbm, S., Bengtsson, A., & Frddin, T. (1997) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749709105321 · Cited by 62
Molderings, G. J., Meis, K., Kolck, U. W., Homann, J., & Frieling, T. (2010) · Immunogenetics · doi:10.1007/s00251-010-0474-8 · Cited by 58
MATSUZAKI, S., CANIS, M., DARCHA, C., FUKAYA, T., YAJIMA, A., & BRUHAT, M. A. (1998) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1998.tb00420.x · Cited by 50
A concise, practical guide to diagnostic assessment for mast cell activation disease
Afrin, L. B., & Molderings, G. J. (2014) · World Journal of Hematology · doi:10.5315/wjh.v3.i1 · Cited by 37
Self-citationMcKinnon, B. D., Evers, J., Bersinger, N. A., & Mueller, M. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1019 · Cited by 32 · cited 1×
“Endometriotic lesions showed higher expression of SP, CGRP and NK1 receptors [126–128].”
BackgroundJardí, F., Fernández-Blanco, J. A., Martínez, V., & Vergara, P. (2014) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.958524 · Cited by 15 · cited 1×
“Additionally, NGF contributes to visceral hyperalgesia in rats via modulating the plasticity of DRG neurons [157] and via mucosal dysfunction to promote MC-nerve direct interaction [158–160].”
Background
Cited by
Nociceptor Sensory Neuron–Immune Interactions in Pain and Inflammation
Pinho-Ribeiro, F. A., Verri, W. A., & Chiu, I. M. (2017) · Trends in Immunology · doi:10.1016/j.it.2016.10.001 · Cited by 1,027
Neurogenic inflammation and its role in migraine
Ramachandran, R. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0676-y · Cited by 310
Mast cell‐neural interactions contribute to pain and itch
Gupta, K., & Harvima, I. T. (2018) · Immunological Reviews · doi:10.1111/imr.12622 · Cited by 296
Self-citationCan Endometriosis-Related Oxidative Stress Pave the Way for New Treatment Targets?
Cacciottola, L., Donnez, J., & Dolmans, M.-M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137138 · Cited by 118
Mast Cell Activation Syndrome: A Primer for the Gastroenterologist
Weinstock, L. B., Pace, L. A., Rezaie, A., Afrin, L. B., & Molderings, G. J. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06264-9 · Cited by 59
Self-citation
Metadata
- Authors
- Aich, A., Afrin, L., & Gupta, K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2015-12-04
- Volume
- 16
- Issue
- 12
- Pages
- 29069-29092
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2188590881
- Cited by
- 157
- References
- 41
- FWCI
- 8.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.